Minimizing the impact of HCV lookback by using RIBA HCV 3.0 SIA.

被引：0
|
作者：
Tegtmeier, GE [1 ]
Edwards, RL [1 ]
Henderson, SE [1 ]
Wright, JE [1 ]
Menitove, JE [1 ]
机构：
[1] Community Blood Ctr, Kansas City, MO USA
来源：
TRANSFUSION | 1998年 / 38卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
S352
引用
收藏
页码：93S / 93S
页数：1
相关论文
共 50 条
  • [1] The impact of HCV genotypes on seroreactivity against HCV antigens immobilized on the RIBA™ 3.0 SIA
    Jain, N
    Quan, S
    Polito, A
    Lau, JYN
    [J]. JOURNAL OF HEPATOLOGY, 1999, 30 (01) : 173 - 173
  • [2] EVALUATION OF RIBA(TM) HCV-2.0 SIA INDETERMINATE SPECIMENS BY RIBA(TM) HCV-3.0 SIA AND HCV-RNA BY PCR
    AIZA, I
    DEMEDINA, M
    LI, XM
    PONIACHIK, J
    BARTHOLOMEW, M
    JEFFERS, LJ
    REDDY, KR
    BERNSTEIN, D
    ROACH, K
    HILL, M
    LARUE, S
    SCHIFF, ER
    [J]. HEPATOLOGY, 1994, 20 (04) : A240 - A240
  • [3] Results of HCV RIBA 2.0 indeterminate testing by using HCV RIBA 3.0
    Stramer, SL
    Brodsky, JP
    Peoples, B
    Porter, RA
    Wiack, M
    [J]. TRANSFUSION, 1999, 39 (10) : 107S - 107S
  • [4] RESOLUTION OF RIBA(TM) HCV-2.0 SIA INDETERMINATE SPECIMENS FROM VOLUNTEER BLOOD-DONORS BY THE RIBA(TM) HCV-3.0 SIA
    QUAN, S
    POLITO, A
    DINELLO, R
    ANDREWS, W
    LEE, F
    SRA, K
    MIAO, D
    CHEN, M
    LEE, S
    NELLES, M
    [J]. TRANSFUSION, 1993, 33 (09) : S34 - S34
  • [5] The impact of HCV genotypes on seroreactivity against HCV antigens mounted on the RIBA 3.0 strip
    Jain, N
    Xu, YL
    Quan, S
    DiNello, R
    Polito, A
    Lau, JYN
    [J]. HEPATOLOGY, 1997, 26 (04) : 233 - 233
  • [6] CORRELATION OF SECOND GENERATION HCV ELISA AND RIBA HCV 2.0 SIA RESULTS
    LAYUG, L
    BLACKWELL, M
    DODD, RY
    SANDLER, SG
    [J]. TRANSFUSION, 1994, 34 (10) : S39 - S39
  • [7] Minimizing retrospective HCV lookback workload: Retesting current samples from RIBA 2.0 indeterminate donors
    Armitage, JB
    Roseff, SD
    Gibble, JW
    Johnson, RD
    Smith, JS
    Carroll, D
    Little, KB
    Williamson, PB
    [J]. TRANSFUSION, 2000, 40 (10) : 31S - 31S
  • [8] RIBA-HCV-2.0-SIA - 18 MONTHS EXPERIENCE
    GOCHENOUR, A
    OBENAUER, M
    VAQUERANO, I
    LE, P
    TRENBEATH, J
    TA, S
    VIGLIETTI, D
    FAUNTLEROY, L
    LAYUG, L
    [J]. TRANSFUSION, 1995, 35 (10) : S125 - S125
  • [9] C33C IS THE DOMINANT ANTIGEN IN THE DETECTION OF EARLY ANTI-HCV SEROCONVERSION BY THE RIBA(TM) HCV-3.0 SIA
    DINELLO, R
    POLITO, A
    QUAN, S
    ANDREWS, W
    SRA, K
    WU, J
    HERRING, B
    LEE, F
    NELLES, M
    [J]. TRANSFUSION, 1993, 33 (09) : S33 - S33
  • [10] Use of HCV version 3 (EIA3) to determine lookback status of EIA2 reactive(R)/RIBA™ HCV 2.0 SIA (RIBA2) indeterminate (IND) donors
    Tobler, LH
    Tegtmeier, G
    Quan, S
    Giachette, C
    Hirschler, N
    Busch, MP
    [J]. TRANSFUSION, 1998, 38 (10) : 93S - 93S
12345